Preclinical experiments counsel that retatrutide may well impact weight problems-linked cancer development. In a very examine led by Marathe et al., retatrutide-induced weightloss reduced tumor engraftment, delayed tumor onset, and appreciably attenuated tumor growth in pancreatic and lung most cancers styles, with higher tumor suppression compared